Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1121-1130 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|June 1, 1988
Internalization of IL-2 by an IL-2-dependent murine T cell lymphoma expressing no detectable cell surface receptors for IL-2H C O'Neill, A Jaworowski
Leukemia|July 14, 2019
Genetic characterization of ABT-199 sensitivity in human AMLRichard Bisaillon, Céline Moison, Clarisse Thiollier, et al.
Leukemia|October 23, 2022
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypesSonja I Berndt, Joseph Vijai, Yolanda Benavente, et al.
Leukemia|October 30, 2022
An MDM2 degrader for treatment of acute leukemiasBridget K Marcellino, Xiaobao Yang, H Ümit Kaniskan, et al.
Leukemia|October 17, 2022
Molecular landscape of immune pressure and escape in aplastic anemiaSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Leukemia|June 30, 2012
Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsX Zhang, T Inukai, K Hirose, et al.
Leukemia|July 4, 2012
Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALLL Lhermitte, R Ben Abdelali, P Villarèse, et al.
Leukemia|July 6, 2012
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II studyF J Giles, P D le Coutre, J Pinilla-Ibarz, et al.
Leukemia|July 6, 2012
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myelomaM A Dimopoulos, M Roussou, M Gkotzamanidou, et al.
Leukemia|July 19, 2012
Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host directionJ Kanda, T Ichinohe, S Kato, et al.
Pageof 963

Showing results (1121-1130 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|June 1, 1988
Internalization of IL-2 by an IL-2-dependent murine T cell lymphoma expressing no detectable cell surface receptors for IL-2H C O'Neill, A Jaworowski
Leukemia|July 14, 2019
Genetic characterization of ABT-199 sensitivity in human AMLRichard Bisaillon, Céline Moison, Clarisse Thiollier, et al.
Leukemia|October 23, 2022
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypesSonja I Berndt, Joseph Vijai, Yolanda Benavente, et al.
Leukemia|October 30, 2022
An MDM2 degrader for treatment of acute leukemiasBridget K Marcellino, Xiaobao Yang, H Ümit Kaniskan, et al.
Leukemia|October 17, 2022
Molecular landscape of immune pressure and escape in aplastic anemiaSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Leukemia|June 30, 2012
Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsX Zhang, T Inukai, K Hirose, et al.
Leukemia|July 4, 2012
Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALLL Lhermitte, R Ben Abdelali, P Villarèse, et al.
Leukemia|July 6, 2012
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II studyF J Giles, P D le Coutre, J Pinilla-Ibarz, et al.
Leukemia|July 6, 2012
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myelomaM A Dimopoulos, M Roussou, M Gkotzamanidou, et al.
Leukemia|July 19, 2012
Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host directionJ Kanda, T Ichinohe, S Kato, et al.
Pageof 963